Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 116662
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.116662
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.116662
Figure 3 Loss of mesenchymal markers and gain of epithelial markers after CALD1 silencing in CAL-51 cells.
A: Western blot analysis showing increased expression of the epithelial markers E-cadherin and ZO-1 in CALD1-silenced CAL-51 cells (small interfering RNA-CALD1) compared with negative control-transfected cells; B: Western blot analysis of mesenchymal markers N-cadherin and Snail in breast cancer cell lines. HeLa cells were used as a positive control for epithelial - mesenchymal transition epithelial-mesenchymal transition, and MCF-7 cells were included as a less aggressive breast cancer cell line; C and D: Densitometric quantification of epithelial and mesenchymal marker expression normalized to β-actin. aP < 0.05; bP < 0.01. N.C: Controls; EMT: Epithelial-mesenchymal transition.
- Citation: AlNuaimi A, Nair VA, Al-Khayyal N, Suliman A, Bou Malhab LJ, Hamoudi R, Hamad M, Talaat IM, Abdel-Rahman WM. Overexpression of low-molecular-weight caldesmon is associated with aggressive phenotypes and epithelial-mesenchymal transition in breast cancer cells. World J Clin Oncol 2026; 17(5): 116662
- URL: https://www.wjgnet.com/2218-4333/full/v17/i5/116662.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i5.116662